Pi Labs, led by Investment Manager Michelle Wilk, explores the complexities and opportunities of U.S. expansion for European startups in a comprehensive FAQ format. Featuring insights from Daniel Glazer of Wilson Sonsini, the FAQ addresses key considerations ranging from differences in VC funding landscapes between the U.S. and Europe to the logistical and legal hurdles of establishing a U.S. presence. The growing interest in U.S. expansion stems from the country’s vast market potential and access to deep capital pools, but founders are cautioned about the substantial risks involved. The initiative aims to be a living resource for tech and life sciences companies operating out of the UK, Europe, and Israel, offering guidance on fundraising and exit strategies to help them thrive in a highly competitive environment.

Venture Capital, Technology, Life Sciences,United States, United Kingdom, Europe, Israel